calendar

2 catalysts · 2 phase 2 initiation

next 91 dayslessmore

MonWedFri

view

sort

Ophthalmology

2

Week of Apr 27, 2026

2

Apr 29, 2026phase 2 initiation104d agoNefro Avillion Clinical Development LLC — siplizumab (Phase II Trial Initiation)siplizumab

Therapy area: Immunology. Indication: Kidney Transplant Rejection

Apr 29, 2026phase 2 initiation104d agoKyowa Kirin Co Ltd — KK-4277 (Phase II Trial Initiation)KK-4277

Therapy area: Immunology. Indication: Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus